Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Non Small Cell Lung Carcinoma NSCLC 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Fulvestrant 64 Letrozole 54 Paclitaxel 49 Trastuzumab 41 pembrolizumab 40 ribociclib 37 Specimen Handling 37 palbociclib 36 Capecitabine 34 Anastrozole 34 Carboplatin 33 Tamoxifen 32 exemestane 30 pertuzumab 28 abemaciclib 28 Magnetic Resonance Spectroscopy 26 Cyclophosphamide 26 trastuzumab deruxtecan 24 Surveys and Questionnaires 21 Biopsy 19 Radiotherapy 18 olaparib 17 Blood Specimen Collection 17 Standard of Care 16 Docetaxel 16 Taxes 14 Mastectomy, Segmental 14 eribulin 13 elacestrant 13 Methods 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × CP protocol × 90 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡